Geode Capital Management LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 1.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,226,159 shares of the biotechnology company’s stock after purchasing an additional 35,544 shares during the quarter. Geode Capital Management LLC’s holdings in Axon Enterprise were worth $1,265,657,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of AXON. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise during the fourth quarter worth about $28,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise during the third quarter worth about $29,000. Sound Income Strategies LLC grew its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth about $30,000. Finally, Lodestone Wealth Management LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth about $35,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Key Headlines Impacting Axon Enterprise
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon’s stronger-than-expected Q1 results and raised 2026 revenue outlook reinforced confidence in accelerating growth. Axon rallies 12% as upbeat 2026 outlook and fresh price-target hike lift sentiment
- Positive Sentiment: A major Wall Street firm raised its price target to $755, helping support bullish sentiment around the stock. Axon rallies 12% as upbeat 2026 outlook and fresh price-target hike lift sentiment
- Positive Sentiment: Axon’s partnership with Echodyne expanded its public safety drone and radar ecosystem, adding another growth catalyst. Echodyne Expands Public Safety Radar Applications Through Partnership with Axon
- Neutral Sentiment: Investor attention remains elevated, but recent Zacks headlines were mainly commentary rather than new fundamental news. Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
- Neutral Sentiment: Analyst coverage remains broadly supportive, with several buy ratings and a high consensus target, reinforcing the longer-term bull case. Axon Enterprise Stock: Analyst Estimates & Ratings
- Negative Sentiment: Recent insider selling may temper enthusiasm for some investors, even though it does not change the company’s operating outlook. Insider Selling: Axon Enterprise (NASDAQ:AXON) Insider Sells 2,000 Shares of Stock
Axon Enterprise Stock Performance
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.47 earnings per share. Analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.
Analyst Ratings Changes
A number of research firms recently weighed in on AXON. Royal Bank Of Canada dropped their target price on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Morgan Stanley set a $600.00 target price on Axon Enterprise in a research report on Thursday, May 7th. UBS Group dropped their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a research report on Thursday, May 7th. Finally, Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.
Read Our Latest Research Report on Axon Enterprise
Insiders Place Their Bets
In related news, Director Jeri Williams sold 157 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at $567,910. This represents a 11.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the transaction, the chief accounting officer owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. This represents a 10.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 3,855 shares of company stock worth $1,837,408 in the last ninety days. Insiders own 4.20% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
